Psybio Therapeau (PSYBF) Stock Price, News & Analysis
Company Description
Psybio Therapeau (OTC Link: PSYBF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $935.8K.
This page collects what Stock Titan holds for PSYBF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Psybio Therapeau (PSYBF) stock last closed at $0.0000. At a market capitalization of $935.8K, PSYBF is classified as a micro-cap stock with approximately 130.6M shares outstanding.
Latest News
Psybio Therapeau has 3 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 1 with negative movement. Key topics include conferences. View all PSYBF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Psybio Therapeau (PSYBF) currently stands at 277.3 thousand shares, representing 0.3% of the float. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Psybio Therapeau (PSYBF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 30.0 to 1000.0 days.
PSYBF Company Profile & Sector Positioning
Psybio Therapeau (PSYBF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing PSYBF often look at related companies in the same sector, including Yulong Eco-Matls Ltd (YECO), Innovation (IPIX), Sqz Biotechnologies Co (SQZB), Braxia Scientifi (BRAXF), and BIORA THERAPEUTICS INC (BIOR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PSYBF's relative position within its industry.